Medisprof

Cluj-Napoca, Cluj 400641

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Melanoma

Studies at this site

• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling